﻿<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:n="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"><url><loc>https://www.indianpharmapost.com/biosynth-carbosynth-expands-peptide-offering-with-acquisition-of-pepscan-12595</loc><lastmod>2022-07-01T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/jubilant-hollisterstier-announces-cad-100-mn-for-montreal-facility-12596</loc><lastmod>2022-07-01T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/lupin-receives-approval-from-usfda-for-paliperidone-extended-release-tablets-12597</loc><lastmod>2022-07-01T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/zydus-receives-final-approval-from-usfda-for-lacosamide-injection-12598</loc><lastmod>2022-07-01T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/h-clinical-adds-commercial-home-health-capabilities-for-pharma-industry-12599</loc><lastmod>2022-07-01T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/akebia-therapeutics-regaining-rights-to-vadadustat-in-the-us-europe-and-china-12600</loc><lastmod>2022-07-01T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/biologicals-have-emerged-as-a-therapy-of-choice-where-traditional-chemical-drugs-fail-dr-bharati-pravin-pawar-12601</loc><lastmod>2022-07-01T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/jb-pharma-acquires-4-paediatric-brands-from-dr-reddys-laboratories-12602</loc><lastmod>2022-07-01T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url>    
</urlset>